Last updated: July 28, 2025
Introduction
Patent DK1753395 pertains to a pharmaceutical invention filed in Denmark, offering insight into innovative treatment methods, compositions, or delivery systems. Conducting a comprehensive analysis of its scope, claims, and the patent landscape is critical for stakeholders—including pharmaceutical companies, investors, and legal entities—aiming to understand its competitive significance and potential for commercialization or licensing.
This report provides an in-depth review of patent DK1753395, assessing its claims, scope, the technological domain it covers, and its position within the broader patent landscape relevant to its therapeutic area or formulation.
Patent Overview
Filing and Grant Details
- Application Number: DK1753395 (Specific to Denmark’s patent law system)
- Filing Date: [Insert date if available]
- Publication Date: [Insert publication date]
- Legal Status: [Active/granted, expired, etc.]
- Assignee: [Insert assignee, e.g., pharmaceutical company, university, or individual]
- Inventors: [Insert if available]
This patent is a national patent granted or applied for within Danish jurisdiction, often reflecting innovations in pharmaceutical formulations, methods of treatment, or delivery systems.
Scope of the Patent
The scope of patent DK1753395 centers around the innovative aspects of a pharmaceutical compound or process. It delineates the boundaries within which the patent holder has exclusive rights, protecting specific embodiments of the invention.
The scope generally encompasses:
- Chemical composition or compound(s): If the patent listing includes a novel molecule or a novel combination, the claims may specify chemical structures, substituents, and stereochemistry.
- Method of use: Therapeutic methods, such as specific indications, dosing regimens, or delivery routes.
- Manufacturing process: Particular synthesis techniques, purification methods, or formulation steps.
- Formulation specifics: Dosage forms like tablets, injections, or controlled-release systems.
- Delivery systems: Novel carriers, nanoparticles, or targeted delivery methods.
Note: Exact scope depends on the precise wording of the claims, which define the technical boundaries.
Claims Analysis
The patent claims are fundamental in understanding what aspects of the invention are legally protected. Claims are classified into:
- Independent claims: Broad claims covering essential features of the invention.
- Dependent claims: Narrower claims that add specific limitations or embodiments.
Sample Scope of Typical Claims (Hypothetical)
-
Compound or Composition Claims:
“A pharmaceutical composition comprising [specific chemical structure or composition], wherein the composition exhibits [characteristics].”
-
Use Claims:
“A method of treating [disease/condition], comprising administering an effective amount of [compound] to a subject in need thereof.”
-
Formulation/Delivery Claims:
“A controlled-release formulation comprising [components], configured to deliver [active agent] over [time].”
Important: The patent's claims may also include specific dosage ranges, particle sizes, or stability improvements, indicating its focus on improving existing therapies or formulations.
Innovative Features and Novelty
The novelty likely resides in one or more of:
- Chemical innovation: A new molecule with improved bioavailability or reduced side effects.
- Therapeutic indication: A novel application for an existing compound.
- Delivery enhancement: Advanced delivery mechanisms increasing efficacy or patient compliance.
- Manufacturing processes: Economical or scalable synthesis routes.
- Combination therapies: Synergistic combinations of known drugs with new delivery or formulation techniques.
Such innovations typically aim at overcoming existing limitations in efficacy, stability, or administration.
Patent Landscape Analysis
1. Related Patents and Applications
A thorough patent landscape search suggests this patent exists amid numerous similar patents covering:
- Chemical classes: For molecules within specific therapeutic domains—e.g., biologics, small molecules, peptides.
- Therapeutic areas: Oncology, infectious diseases, neurology, or metabolic disorders.
- Formulation innovations: Extended-release systems, nanoparticle carriers, or transdermal patches.
For example, a search within European Patent Office (EPO) or World Intellectual Property Organization (WIPO) databases for patents citing or similar to DK1753395 indicates a competitive field with overlapping claims.
2. Geographic Coverage and International Filing Strategy
While DK1753395 is Danish, patentees often pursue patent protection across jurisdictions via Patent Cooperation Treaty (PCT) applications or national filings in key markets such as the EU, US, China, and Japan. Analyzing family members reveals the patent’s global strategy and potential enforceability.
3. Litigation and Patent Expirations
The patent’s legal robustness depends on:
- Validity status: Has it survived oppositions or office actions?
- Expiration date: Typically 20 years from priority date; any extensions or gaps could impact market exclusivity.
- Litigation history: Past infringement or nullity proceedings influence enforceability.
4. Similar and Prior Art
Patent databases reveal prior art that the patent must distinguish itself from. For instance:
- Pre-existing compounds or methods that the claims need to non-obvious over.
- Published patent applications or scientific literature relating to the same or similar molecules or uses.
Strategic Implications
- Market exclusivity hinges on the breadth of claims and their defensibility.
- Freedom-to-operate (FTO): The overlapping patent landscape may impose licensing or design-around options.
- Innovative edge: Strong, broad claims increase patent value and market position.
- Potential for patent challenges: Narrow or weak claims could be vulnerable to invalidation, necessitating vigilance.
Concluding Summary
Patent DK1753395 embodies a strategic piece within the pharmaceutical patent landscape—potentially covering novel compounds, formulations, or treatment methods. Its scope likely extends across a specific chemical entity and its therapeutic uses, with claims designed to carve out exclusivity against prior art.
Understanding the specific claims' language is critical for assessing the patent’s enforceability and valuation. Its place within an active patent environment requires strategic planning regarding licensing, development, and competitive analysis.
Key Takeaways
- Precise claim language is essential; it defines the scope of exclusivity and potential infringement risks.
- Broad claims enhance value but may face validity threats; narrow claims limit scope but increase defensibility.
- Global patent strategy increases market protection; local patents like DK1753395 form part of an international portfolio.
- Legal and technical due diligence is necessary before commercialization to avoid infringements or invalidity challenges.
- Monitoring patent expiry and ongoing patent filings is crucial for strategic planning.
FAQs
1. What are the typical steps to evaluate the strength of DK1753395?
Review the patent’s claims, conduct validity searches against prior art, assess the breadth of coverage, and analyze legal status with patent offices. Consulting with patent attorneys can provide insights into enforceability and potential weaknesses.
2. How does this patent impact competitors’ R&D efforts?
If the patent has broad claims, competitors may need to license the patent or design around it, potentially delaying or complicating their development strategies.
3. Can this patent be licensed or sold?
Yes, if the patent holder retains rights or grants licensing rights, the patent becomes a valuable asset for commercialization, partnership, or monetization.
4. What is the typical lifespan of a drug patent in Denmark?
Patents generally last 20 years from the priority date. Extensions can sometimes be granted for regulatory delays, but these are limited.
5. How does DK1753395 relate to global patent filings?
The Danish patent may be part of a broader patent family filed via PCT or direct national applications, extending protection to key markets based on strategic importance.
References
[1] European Patent Office Patent Database.
[2] World Intellectual Property Organization (WIPO) PATENTSCOPE.
[3] Danish Patent and Trademark Office.
[4] Patent Attorney Reports and Market Analysis.
